HLA-C and neoplasm: Lymphocyte-activation gene 3 (LAG-3), a co-inhibitory receptor that highly expresses on various immune cells, binds to MHC (major histocompatibility complex) class II molecules expressed by tumor cells to negatively regulate the anti-tumor immunity [52].